Status:
UNKNOWN
LCI in Chronic Atrophic Gastritis and Early Gastric Cancer
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences
Conditions:
CAG - Chronic Atrophic Gastritis
EGC - Early Gastric Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Color change is a useful marker for the endoscopic identification of chronic atrophic gastritis (CAG) and gastric cancer (GC). Several histopathological studies have suggested a correlation between ce...
Detailed Description
In this study, 10 patients diagnosed with CAG or early GC by esophagogastroduodenoscopy at Fifth Medical Center of Chinese PLA General Hospital between September 2023 and December 2023 will be enrolle...
Eligibility Criteria
Inclusion
- Patients diagnosed with chronic atrophic gastritis (CAG) and early gastric cancer (EGC). by esophagogastroduodenoscopy
Exclusion
- Inappropriate LCI images as a result of bleeding, ulceration, or excessive mucosal congestion
- Patients with severe anemia or portal hypertension
- Patients diagnosed as having a mixture of the differentiated and undifferentiated types of gastric carcinoma, or having helicobacter pylori infection
Key Trial Info
Start Date :
September 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06152263
Start Date
September 30 2023
End Date
December 30 2023
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fifth Medical Center of Chinese PLA General Hosptial
Beijing, Beijing Municipality, China, 100039